This is a preview of subscription content, log in via an institution to check access.
Notes
The study was supported in part by funding from Pfizer Inc.
Reference
Kimura SI, et al. Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases. European Journal of Clinical Microbiology and Infectious Diseases : 11 Jan 2015. Available from: URL: http://doi.org/10.1007/s10096-014-2311-8
Rights and permissions
About this article
Cite this article
Pre-emptive antifungal treatment: similar outcomes at lower cost. PharmacoEcon Outcomes News 720, 26 (2015). https://doi.org/10.1007/s40274-015-1865-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1865-8